European market opening suggests a subtle inflection point for risk assets

Fidelity European Trust

As the calendar turned to November, European equities showed signs of life. In the UK the main index rose around 0.1 %, while Paris, Milan and Frankfurt delivered stronger gains of about 0.2 %, 0.6 % and 0.9 % respectively. Data published for the eurozone manufacturing sector registered a PMI reading of 50 in October, up from 49.8 the prior month.

After a stretch where central‑bank decisions, macro uncertainty and earnings volatility loomed large, the fact that production is rising (albeit slowly) removes one layer of concern. Combined with commentary suggesting that corporate earnings remain solid and that the window for share buy‑backs may be reopening, the conditions for risk appetite appear to be improving.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers.

Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance.

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

Search

Search